Stock Scorecard
Stock Summary for Perrigo Company plc (PRGO) - $31.27 as of 4/25/2024 8:59:48 PM EST
Total Score
9 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PRGO
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PRGO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PRGO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for PRGO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for PRGO
Financial Details for PRGO
Company Overview |
|
|---|---|
| Ticker | PRGO |
| Company Name | Perrigo Company plc |
| Country | USA |
| Description | Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/7/2024 |
Stock Price History |
|
| Last Day Price | 31.27 |
| Last Day Price Updated | 4/25/2024 8:59:48 PM EST |
| Last Day Volume | 1,083,923 |
| Average Daily Volume | 1,378,132 |
| 52-Week High | 39.23 |
| 52-Week Low | 25.52 |
| Last Price to 52 Week Low | 22.53% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 101.20 |
| Sector PE | 61.73 |
| 5-Year Average PE | 11.12 |
| Free Cash Flow Ratio | 5.64 |
| Industry Free Cash Flow Ratio | 12.66 |
| Sector Free Cash Flow Ratio | 30.74 |
| Current Ratio Most Recent Quarter | 1.79 |
| Total Cash Per Share | 5.54 |
| Book Value Per Share Most Recent Quarter | 35.19 |
| Price to Book Ratio | 0.86 |
| Industry Price to Book Ratio | 5.66 |
| Sector Price to Book Ratio | 22.08 |
| Price to Sales Ratio Twelve Trailing Months | 0.88 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.48 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
| Total Shares Outstanding | 135,516,000 |
| Market Capitalization | 4,237,585,320 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 3/7/2024 |
| Last Dividend Amount | 0.27 |
| Current Dividend Amount | 0.28 |
| Dividend Aristocrat? | |
| Trailing Annual Dividend Rate | 1.10 |
| Trailing Annual Dividend Yield | 3.51% |
| Forward Annual Dividend Rate | 1.18 |
| Forward Annual Dividend Yield | 3.77% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 2.97% |
| 5-Year Average Dividend Yield | 2.50% |
| 1-Year Dividend Growth Rate Percentage | 5.00% |
| 3-Year Dividend Growth Rate Percentage | 6.65% |
| 5-Year Dividend Growth Rate Percentage | 7.42% |
| All-Time Dividend Growth Rate Percentage | 12.16% |
| Dividend Payout Ratio | -3,650.00% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -63.60% |
| Annual Earnings Growth | 90.30% |
| Reported EPS 12 Trailing Months | -0.03 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 2.58 |
| Net Income Twelve Trailing Months | -10,800,000 |
| Net Income Past Year | -12,700,000 |
| Net Income Prior Year | -130,900,000 |
| Quarterly Revenue Growth YOY | 0.10% |
| 5-Year Revenue Growth | -0.32% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 751,300,000 |
| Total Cash Past Year | 751,300,000 |
| Total Cash Prior Year | 555,200,000 |
| Net Cash Position Most Recent Quarter | -7,465,400,000 |
| Net Cash Position Past Year | -7,465,400,000 |
| Long Term Debt Past Year | 8,216,700,000 |
| Long Term Debt Prior Year | 4,122,200,000 |
| Total Debt Most Recent Quarter | 8,216,700,000 |
| Equity to Debt Ratio Past Year | 0.37 |
| Equity to Debt Ratio Most Recent Quarter | 0.37 |
| Total Stockholder Equity Past Year | 4,767,900,000 |
| Total Stockholder Equity Prior Year | 4,848,600,000 |
| Total Stockholder Equity Most Recent Quarter | 4,767,900,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.07 |
| MACD Signal | -0.01 |
| 20-Day Bollinger Lower Band | 28.10 |
| 20-Day Bollinger Middle Band | 31.28 |
| 20-Day Bollinger Upper Band | 34.47 |
| Beta | 0.65 |
| RSI | 53.27 |
| 50-Day SMA | 31.86 |
| 200-Day SMA | 37.01 |
System |
|
| Modified | 4/25/2024 9:25:18 AM EST |